ERIN SUHIR: Open Payments
NPI 1528426947 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 14 payments from 8 companies in 2025. Trend: 2023 $243 · 2024 $381 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 4 | $208 |
| Alkermes, Inc. | 2 | $62 |
| Indivior Inc. | 2 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| SCPHARMACEUTICALS INC. | 1 | $30 |
| Abbott Laboratories | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: BRIXADI, VIVITROL, SUBLOCADE, INGREZZA, FUROSCIX, AVEIR, VRAYLAR, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
